GlassScriptPhysician profile
Shuyan Wei
NPI 1376939819
$11,545.07
in general payments reported to CMS, 2019-2025
30 companies · $2,198 in 2025
The $2,198 reported for 2025 was more than what 86% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $540 · 2021: $1,115 · 2022: $890 · 2023: $2,357 · 2024: $3,225 · 2025: $2,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,779.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,822.01 | 2021-2025 | Ranger, Enroute Transcarotid Neuroprotection System, General - Catheters |
| Abbvie INC. | $1,762.80 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants, Botox |
| Axogen | $1,280.15 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Medtronic, INC. | $831.03 | 2024-2025 | Endurant Iis, V-Loc 180 |
| Silk Road Medical, INC. | $707.27 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Depuy Synthes Sales INC. | $581.49 | 2022-2025 | Matrixmidface, Trumatch, Matrixmandible |
| Inari Medical, INC. | $426.71 | 2020-2021 | |
| Allergan, INC. | $398.62 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $365.61 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $357.49 | 2019-2020 | |
| Becton, Dickinson and Company | $333.71 | 2023-2024 | Rotarexs 6 F X 135 Cm, Progel Applicator Spray Tips, Hemosphere |
| Endologix LLC | $332.31 | 2021-2022 | |
| Tela Bio, INC. | $322.61 | 2020-2024 | Ovitex 2s |
| Baxter Healthcare | $279.60 | 2019-2025 | Artiss |
| Cook Medical LLC | $247.80 | 2024 | Zilver Ptx |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $204.91 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $168.74 | 2021 | |
| Ethicon US, LLC | $164.92 | 2019-2022 | |
| Biom'Up France Sas | $150.54 | 2021 | |
| Kerecis Limited | $125.89 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $117.65 | 2019 | |
| Acell, INC. | $101.96 | 2019-2020 | |
| Coopersurgical, INC. | $87.38 | 2019 | |
| Stryker Corporation | $82.76 | 2023-2024 | Variax, 1788 |
| Mentor Worldwide LLC | $78.63 | 2022 | |
| Integra Lifesciences Corporation | $61.98 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sanara Medtech INC. | $61.53 | 2021 | |
| Ormco Corporation | $50.00 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $23.07 | 2019 | |
| Convatec INC. | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shuyan Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.